Teva

AJOVY SYRINGE

Manufacturer:

Teva

Ajovy Syringe HCPCS:

J3031

HCPCS Code Descriptor:

Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)

Category:

J Code

Ajovy Syringe NDCs:

51759-0202-22, 51759-0204-10, 51759-0202-10

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ajovy Syringe:

AJOVY SYRINGE is a Neurology drug manufactured by Teva and administered via the Subcutaneous route of administration. The J Code: J3031 is aligned to the drug AJOVY SYRINGE.

ACCESS PRICING AND MORE BY REGISTERING

J3031 Added Date:

October 1, 2019

J3031 Effective Date:

October 1, 2019

J3031 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ajovy Syringe billing and coding information.
Ajovy Syringe patient assistance information can be found through Teva’s Shared Solutions at the URL: https://www.ajovyhcp.com/support/savings
AJOVY SYRINGE prescribing information can be found at the link below:
Information regarding AJOVY SYRINGE’s side effects can be found at MedlinePlus